Concordance with NCCN colorectal cancer guidelines and ASCO/NCCN quality measures: An NCCN institutional analysis

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 7, Issue 8, 2009, Pages 895-904

  Romanus, Dorothy ^a   Weiser, Martin R ^b   Skibber, John M ^c   Ter Veer, Anna ^d   Niland, Joyce C ^d   Wilson, John L ^e   Rajput, Ashwani ^f   Wong, Yu Ning ^g   Benson III, Al B ^h   Shibata, Stephen ^d   Schrag, Deborah ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^e OHIO STATE UNIVERSITY   (United States)

^f ROSWELL PARK CANCER INSTITUTE   (United States)

^g FOX CHASE CANCER CENTER   (United States)

^h NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Clinical practice guidelines; Colorectal cancer; Quality improvement; Quality measurement

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER STAGING; COLORECTAL CANCER; EVIDENCE BASED MEDICINE; FEMALE; HEALTH CARE DELIVERY; HEALTH CARE SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; QUALITY CONTROL; TREATMENT REFUSAL;

EID: 70349859888     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2009.0059     Document Type: Article

References (15)

1. Herdman R, McGuire W, Simone J. Influencing Cancer Policy. Tracing the influence of an Institute of Medicine effort to improve the quality of cancer care. Health Affairs 2006;25:800-807.
2. Hewitt M, Simone JV. Ensuring Quality Cancer Care. Washington, D.C.: National Academy Press; 1999: 211-225.
3. Lipscomb J, Gotay CC, Snyder C. Outcomes Assessment in Cancer. Measures, Methods and Applications. New York: Cambridge University Press; 2005.
4. Malin JL, Schneider EC, Epstein AM, et al. Results of the National Initiative for Cancer Care Quality: how can we improve the quality of cancer care in the United States? J Clin Oncol 2006;244:626-634.
5. American Cancer Society. American Cancer Society Extramural Grants Programs in Effect September 1, 1998. Atlanta: American Cancer Society; 1998.
6. American Society of Clinical Oncology. The Quality Oncology Practice Initiative. Available at: http://qopi.asco.org. Accessed July 22, 2009.
7. National Cancer Institute. Cancer Topics: Colon and Rectal Cancer. Available at: http://www.cancer.gov/cancertopics/types/colon-and-rectal. Accessed July 22, 2009.
8. Cancer Trends Progress Report - 2007 Update. National Cancer Institute, NIH, DHHS, Bethesda, MD, December 2007. Available at: http://progressreport. cancer.gov. Accessed July 22, 2009.
9. Schrag D. The price tag on progress-chemotherapy for colorectal cancer. N Engl J Med 2004;351:317-319. (Pubitemid 38944397)
10. Engstrom PF, Arnoletti JP, Benson AB, et al. The NCCN Clinical Practice Guidelines in Oncology: Colon Cancer, version 2, 2009. Available at: http://www.nccn.org/professionals/physician-gls/PDF/colon.pdf. Accessed July 23, 2009.
11. Engstrom PF, Arnoletti JP, Benson AB, et al. The NCCN Clinical Practice Guidelines in Oncology: Rectal Cancer, version 2, 2009. Available at: http://www.nccn.org/professionals/physician-gls/PDF/rectal.pdf. Accessed July 23, 2009.
12. ASCO/NCCN Quality Measures: Breast and Colorectal Cancers. Press Release. Available at: http://www.nccn.org/professionals/quality-measures/default.asp. Accessed July 22, 2009.
13. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383. (Pubitemid 17055592)
14. Ries LAG, Melbert D, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2005. National Cancer Institute. Bethesda, MD. Available at: http://seer.cancer.gov/csr/1975-2005/. Accessed July 22, 2009.
15. Hassett MJ, Hughes M, Niland J, et al. Selecting high priority quality measures for breast cancer quality improvement. Med Care 2008;46:762-770.